Clinical Trial Update: Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating reduced-intensity stem cell transplantation for children with relapsed neuroblastoma after autologous transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED